Home / Publications / Knowledge & Development / Why Ukraine is highly attractive for clinical research

Why Ukraine is highly attractive for clinical research

Ukraine is highly attractive for clinical researchWhy Ukraine? All the advantages of the Ukrainian market in comparison with the other emerging countries of Europe are summarized here in 7 key items:

1. Central location
Ukraine is situated in the center of Eastern Europe, on the crossroads of important transportation routes from Europe to Asia and from the Scandinavian countries to the Mediterranean region.

2. Huge naïve patient pool
Ukraine is a big country with a centralized state healthcare system and, at the same time, has one of the lowest rate of international clinical trials/population in Europe.

3. Research-friendly country regulations
The Regulatory Authorities in Ukraine during the last years have made some key regulating steps improving and simplifying the country clinical research environment: quicker start-up, shorter list of applying documents, less IMP import costs.

4. Highly educated monitors
Due to the unique social background, the highly educated employees with medical and pharmacological backgrounds represent around 90% of the clinical research staff. This percentage will not go down in the near future in Ukraine.

5. Highly motivated investigators
Investigators are highly interested in participation in more international clinical trials and do their best demonstrating the excellent study results and their real willingness to build perspective long-term partnerships with the sponsors and CROs.

6. Low project costs per subject
On average, the investigators’/hospitals’/institutions’ study fees and the monitoring cost per study subject in Ukraine are 25% lower than those in the EU. Moreover, quick and efficient study enrollment in Ukraine reduces the time required for recruitment, which saves money dramatically.

7. High quality performance
Most customers conducting clinical trials in Ukraine are impressed by quick recruitment and high quality performance in Ukraine. It is a fact!

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Publications of

Sergii Gromov


  1. I would actually move quality & motivation higher up the rank.
    High quality is what Ukrainian investigators together with CROs have achieved over years of diligent work and this is a key for successful R&D. Our quality is something to be proud of and crucial for Sponsors, thus I would place it first 🙂
    Opportunity to learn, implement top of the line threatments, use state of the art technologies and be a part of “global team” for better future, fuels up Ukrainian Investigators’ motivation more (in my opinion) than motivation of Investigators in countries, where this opportunity is more readily available or taken for granted. Thus, I would place motivation right after naïve patient pool item.

Leave a Reply

Spelling error report

The following text will be sent to our editors: